Deficient Adipogenesis of Scleroderma Patient and Healthy African American Monocytes-Reference-Cited by-同舟云学术

Deficient Adipogenesis of Scleroderma Patient and Healthy African American Monocytes

Published:2017-04-03 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Lee Rebecca,Reese Charles,Carmen-Lopez Gustavo,Perry Beth,Bonner Michael,Zemskova Marina,Wilson Carole L.,Helke Kristi L.,Silver Richard M.,Hoffman Stanley,Tourkina Elena

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference53 articles.

1. Transforming growth factor beta and progression of renal disease;August;Kidney Int. Suppl.,2003

2. PPARs: therapeutic targets for metabolic disease;Berger;Trends Pharmacol. Sci.,2005

3. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides;Bernatchez;Proc. Natl. Acad. Sci. U.S.A.,2005

4. Characterization of the adipocyte cellular lineage in vivo;Berry;Nat. Cell Biol.,2013

5. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation;Bucci;Nat. Med.,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of caveolin-1 in skin diseases;Frontiers in Immunology;2022-11-30

2. Oral Mesenchymal Stromal Cells in Systemic Sclerosis: Characterization and Response to a Hyaluronic-Acid-Based Biomaterial;Applied Sciences;2021-08-31

3. The Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple Organs;Journal of Pharmacology and Experimental Therapeutics;2021-04-20

4. The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review;Journal of Autoimmunity;2020-09

5. Caveolin-1 as a target in prevention and treatment of hypertrophic scarring;npj Regenerative Medicine;2019-04-26